Will J&J's pharmaceutical sales surpass $15 billion in Q4 2024? | Binary | | | 2 months ago | |
Will J&J's 2024 adjusted EPS fall within its revised guidance? | Binary | | | 2 months ago | |
Will Johnson & Johnson's stock price increase by 5% by September 20, 2024, following the acquisition announcement? | Binary | | | 4 months ago | |
What will be J&J's oncology drug sales in Q4 2024? | Categorical | | | 2 months ago | |
Will Johnson & Johnson meet its revised 2024 revenue forecast by end of fiscal year? | Binary | | | 2 months ago | |
What will be J&J's operational sales growth for 2024? | Categorical | | | 2 months ago | |
What will be J&J's MedTech sales in Q4 2024? | Categorical | | | 2 months ago | |
What will be the total deal value of Johnson & Johnson's acquisition of V-Wave by December 31, 2026? | Categorical | | | 4 months ago | |
Will V-Wave achieve its first milestone payment from Johnson & Johnson by June 30, 2025? | Binary | | | 4 months ago | |
When will Johnson & Johnson launch the first product using V-Wave's Ventura® technology by December 31, 2025? | Categorical | | | 4 months ago | |
What will be the revenue growth of Johnson & Johnson's MedTech cardiovascular portfolio by December 31, 2025? | Categorical | | | 4 months ago | |
Will Johnson & Johnson complete the acquisition of V-Wave by December 31, 2024? | Binary | | | 4 months ago | |
